Sarah E. Vermeer

机构：Rijnstate Hospital · ORCID：0000-0002-1237-1779

发表论文 72 篇 · 总被引 10228 次 · h-index 27

代表论文

• Stroke genetics informs drug discovery and risk prediction across ancestries (2022 · Nature · 被引 638)
• The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial (2015 · The Lancet · 被引 338)
• Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial (2020 · The Lancet · 被引 199)
• Risk Factors and Causes of Ischemic Stroke in 1322 Young Adults (2022 · Stroke · 被引 141)
• Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial (2021 · The Lancet Neurology · 被引 105)
• Hyperglycemia predicts poststroke infections in acute ischemic stroke (2017 · Neurology · 被引 64)